Rankings
▼
Calendar
NVCR Q2 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q2 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$134M
+15.2% YoY
Gross Profit
$105M
78.6% margin
Operating Income
-$12M
-9.2% margin
Net Income
-$15M
-11.0% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
-0.9%
Cash Flow
Operating Cash Flow
$26M
Free Cash Flow
$24M
Stock-Based Comp.
$28M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$700M
Stockholders' Equity
$397M
Cash & Equivalents
$349M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$134M
$116M
+15.2%
Gross Profit
$105M
$90M
+16.0%
Operating Income
-$12M
$7M
-284.4%
Net Income
-$15M
$2M
-984.7%
Geographic Segments
UNITED STATES
$87M
65%
GERMANY
$25M
19%
JAPAN
$9M
7%
EMEA, Exculding Germany
$7M
5%
CHINA
$5M
4%
← FY 2021
All Quarters
Q3 2021 →